Quick Take: Gilgamesh Pharmaceuticals today announced the closing of a $27 million Series A round of funding led by Prime Movers Lab. In addition to Prime Movers Lab, investors included the Noetic Psychedelic Fund LP, Gron Ventures, Route 66 Ventures, JLS Fund, and Palo Santo Investors. The company will use the investment to expand its team, continue…